ALOPM — Oncodesign Precision Medicine Opm SA Cashflow Statement
0.000.00%
- €6.90m
- €5.11m
- €1.07m
Annual cashflow statement for Oncodesign Precision Medicine Opm SA, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ||||
Standards: | — | — | — | — |
Status: | fx Preliminary | fx Preliminary | fx Preliminary | fx Preliminary |